Objectives
The aim of this study is to systematically evaluate the diagnostic ability of the contrast‐enhanced ultrasound (CEUS) liver imaging reporting and data system (LI‐RADS) in hepatocellular carcinoma (HCC).
Methods
We searched relevant studies from PubMed, Medline, and Embase database. After literature search, duplicate removal, and data extraction, we calculated and analyzed the pooled sensitivity, pooled specificity, pooled odds ratios of diagnostic, pooled likelihood ratio (LR) of positive and negative, and area under the curve (AUC), accuracy, and F1 score to evaluate the diagnostic value of CEUS LI‐RADS for HCC.
Results
Thirteen studies and 6491 patients were included in this analysis. The pooled sensitivity and pooled specificity were 0.72 (95% confidence interval [CI], 0.70–0.73) and 0.92 (95% CI, 0.91–0.93), respectively. The positive LR was 8.02 (95% CI, 4.93–13.06) and the negative LR was 0.31 (95% CI, 0.27–0.37). The pooled diagnostic odds ratio was 27.91 (95% CI, 15.39–50.63). The overall AUC was 0.8406 and the accuracy was 0.77.
Conclusions
CEUS LI‐RADS is an effective and promising method to diagnose HCC.